322 results
Page 8 of 17
8-K
EX-99.2
pjng3fo25glgn3hak2
27 Oct 11
Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development
12:00am
8-K
EX-99.2
1ns971gmy7euubvzl8
28 Jul 11
Important Clinical Data and Strong Financial Results
12:00am
8-K
EX-99.2
krrrs5o
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.2
20fu7 lx3
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am